Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence.
Neuropsychopharmacology
; 43(4): 739-750, 2018 03.
Article
in En
| MEDLINE
| ID: mdl-28857070
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrrolidines
/
Benzamides
/
Receptors, Opioid, kappa
/
Cocaine-Related Disorders
/
Narcotic Antagonists
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Neuropsychopharmacology
Journal subject:
NEUROLOGIA
/
PSICOFARMACOLOGIA
Year:
2018
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom